TY - JOUR
T1 - Improving the quality of surveillance colonoscopy in inflammatory bowel disease
AU - Iacucci, Marietta
AU - Cannatelli, Rosanna
AU - Tontini, Gian Eugenio
AU - Panaccione, Remo
AU - Danese, Silvio
AU - Fiorino, Gionata
AU - Matsumoto , Takayuki
AU - Kocchar, Gursimran S
AU - Shen, Bo
AU - Kiesslich, Ralf
AU - Ghosh, Subrata
PY - 2019/12
Y1 - 2019/12
N2 - Several recommendations have addressed the topic of improving the quality of surveillance colonoscopy in inflammatory bowel disease. However, there is variation between these recommendations, in part due to the absence of well-defined quality indicators, suggesting that these quality indicators should be studied and developed. We did a systematic review of evidence related to surveillance colonoscopy in inflammatory bowel disease to look at the different variables in this practice and offer a critique of the quality control measures before, during, and after the procedure. We identified several key quality measures that could be adopted in clinical practice, including control of inflammation, optimal bowel preparation, ideal time allocation, training, sedation, detection and characterisation of lesions, therapeutic management of the lesions, and colonoscopic reports. However, further primary research and consensus reports are needed to continue developing roadmaps at a global level.
AB - Several recommendations have addressed the topic of improving the quality of surveillance colonoscopy in inflammatory bowel disease. However, there is variation between these recommendations, in part due to the absence of well-defined quality indicators, suggesting that these quality indicators should be studied and developed. We did a systematic review of evidence related to surveillance colonoscopy in inflammatory bowel disease to look at the different variables in this practice and offer a critique of the quality control measures before, during, and after the procedure. We identified several key quality measures that could be adopted in clinical practice, including control of inflammation, optimal bowel preparation, ideal time allocation, training, sedation, detection and characterisation of lesions, therapeutic management of the lesions, and colonoscopic reports. However, further primary research and consensus reports are needed to continue developing roadmaps at a global level.
UR - https://www.ncbi.nlm.nih.gov/pubmed/31696831
U2 - 10.1016/S2468-1253(19)30194-3
DO - 10.1016/S2468-1253(19)30194-3
M3 - Review article
SN - 2468-1253
VL - 4
SP - 971
EP - 983
JO - The Lancet Gastroenterology & Hepatology
JF - The Lancet Gastroenterology & Hepatology
IS - 12
ER -